nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—HTR2B—Sorafenib—kidney cancer	0.0808	0.157	CbGbCtD
Ropinirole—HTR2C—Sorafenib—kidney cancer	0.0526	0.102	CbGbCtD
Ropinirole—CYP2D6—Temsirolimus—kidney cancer	0.0517	0.101	CbGbCtD
Ropinirole—CYP3A4—Everolimus—kidney cancer	0.0487	0.0946	CbGbCtD
Ropinirole—CYP1A2—Pazopanib—kidney cancer	0.033	0.0641	CbGbCtD
Ropinirole—CYP3A4—Temsirolimus—kidney cancer	0.0329	0.0639	CbGbCtD
Ropinirole—CYP2D6—Pazopanib—kidney cancer	0.0272	0.0528	CbGbCtD
Ropinirole—CYP1A2—Erlotinib—kidney cancer	0.0235	0.0457	CbGbCtD
Ropinirole—CYP2D6—Erlotinib—kidney cancer	0.0194	0.0377	CbGbCtD
Ropinirole—CYP1A2—Sorafenib—kidney cancer	0.0191	0.0372	CbGbCtD
Ropinirole—CYP3A4—Pazopanib—kidney cancer	0.0173	0.0336	CbGbCtD
Ropinirole—CYP2D6—Sorafenib—kidney cancer	0.0158	0.0306	CbGbCtD
Ropinirole—CYP2D6—Vinblastine—kidney cancer	0.0156	0.0303	CbGbCtD
Ropinirole—CYP3A4—Erlotinib—kidney cancer	0.0123	0.024	CbGbCtD
Ropinirole—CYP3A4—Paclitaxel—kidney cancer	0.0113	0.0219	CbGbCtD
Ropinirole—CYP3A4—Sorafenib—kidney cancer	0.01	0.0195	CbGbCtD
Ropinirole—CYP3A4—Vinblastine—kidney cancer	0.0099	0.0192	CbGbCtD
Ropinirole—CYP3A4—Vincristine—kidney cancer	0.00973	0.0189	CbGbCtD
Ropinirole—CYP2D6—Doxorubicin—kidney cancer	0.00957	0.0186	CbGbCtD
Ropinirole—CYP3A4—Sunitinib—kidney cancer	0.00812	0.0158	CbGbCtD
Ropinirole—CYP3A4—Doxorubicin—kidney cancer	0.00608	0.0118	CbGbCtD
Ropinirole—CYP1A2—urine—kidney cancer	0.000355	0.129	CbGeAlD
Ropinirole—HTR2A—urine—kidney cancer	0.000277	0.101	CbGeAlD
Ropinirole—CYP3A4—urine—kidney cancer	0.000257	0.0937	CbGeAlD
Ropinirole—CYP2D6—urine—kidney cancer	0.000253	0.0922	CbGeAlD
Ropinirole—HTR1D—kidney—kidney cancer	0.000132	0.0482	CbGeAlD
Ropinirole—HTR2B—cortex of kidney—kidney cancer	0.00012	0.0436	CbGeAlD
Ropinirole—HTR1A—renal system—kidney cancer	0.000114	0.0415	CbGeAlD
Ropinirole—ADRA2C—nephron tubule—kidney cancer	0.00011	0.0401	CbGeAlD
Ropinirole—ADRA2C—renal system—kidney cancer	0.0001	0.0365	CbGeAlD
Ropinirole—ADRA2C—kidney—kidney cancer	9.67e-05	0.0353	CbGeAlD
Ropinirole—ADRA2C—cortex of kidney—kidney cancer	9.42e-05	0.0344	CbGeAlD
Ropinirole—ADRA2C—cardiac atrium—kidney cancer	8.96e-05	0.0327	CbGeAlD
Ropinirole—CYP1A2—renal system—kidney cancer	8.68e-05	0.0317	CbGeAlD
Ropinirole—ADRA2A—cortex of kidney—kidney cancer	7.51e-05	0.0274	CbGeAlD
Ropinirole—ADRA2A—gonad—kidney cancer	7.16e-05	0.0261	CbGeAlD
Ropinirole—ADRA2A—cardiac atrium—kidney cancer	7.15e-05	0.0261	CbGeAlD
Ropinirole—Flatulence—Capecitabine—kidney cancer	6.95e-05	0.000156	CcSEcCtD
Ropinirole—Dry skin—Doxorubicin—kidney cancer	6.92e-05	0.000156	CcSEcCtD
Ropinirole—Dysgeusia—Capecitabine—kidney cancer	6.9e-05	0.000155	CcSEcCtD
Ropinirole—Dizziness—Sunitinib—kidney cancer	6.9e-05	0.000155	CcSEcCtD
Ropinirole—Feeling abnormal—Gemcitabine—kidney cancer	6.9e-05	0.000155	CcSEcCtD
Ropinirole—Shock—Paclitaxel—kidney cancer	6.9e-05	0.000155	CcSEcCtD
Ropinirole—Vomiting—Sorafenib—kidney cancer	6.9e-05	0.000155	CcSEcCtD
Ropinirole—Orthostatic hypotension—Doxorubicin—kidney cancer	6.89e-05	0.000155	CcSEcCtD
Ropinirole—Abdominal pain upper—Doxorubicin—kidney cancer	6.89e-05	0.000155	CcSEcCtD
Ropinirole—Nervous system disorder—Paclitaxel—kidney cancer	6.87e-05	0.000155	CcSEcCtD
Ropinirole—Hypokalaemia—Doxorubicin—kidney cancer	6.87e-05	0.000155	CcSEcCtD
Ropinirole—Thrombocytopenia—Paclitaxel—kidney cancer	6.86e-05	0.000154	CcSEcCtD
Ropinirole—Tachycardia—Paclitaxel—kidney cancer	6.84e-05	0.000154	CcSEcCtD
Ropinirole—Rash—Sorafenib—kidney cancer	6.84e-05	0.000154	CcSEcCtD
Ropinirole—Dermatitis—Sorafenib—kidney cancer	6.83e-05	0.000154	CcSEcCtD
Ropinirole—Back pain—Capecitabine—kidney cancer	6.82e-05	0.000153	CcSEcCtD
Ropinirole—Breast disorder—Doxorubicin—kidney cancer	6.82e-05	0.000153	CcSEcCtD
Ropinirole—Skin disorder—Paclitaxel—kidney cancer	6.81e-05	0.000153	CcSEcCtD
Ropinirole—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.79e-05	0.000153	CcSEcCtD
Ropinirole—Headache—Sorafenib—kidney cancer	6.79e-05	0.000153	CcSEcCtD
Ropinirole—HTR2A—renal system—kidney cancer	6.79e-05	0.0248	CbGeAlD
Ropinirole—Muscle spasms—Capecitabine—kidney cancer	6.78e-05	0.000153	CcSEcCtD
Ropinirole—Hyperhidrosis—Paclitaxel—kidney cancer	6.78e-05	0.000153	CcSEcCtD
Ropinirole—Diarrhoea—Dactinomycin—kidney cancer	6.76e-05	0.000152	CcSEcCtD
Ropinirole—Nasopharyngitis—Doxorubicin—kidney cancer	6.75e-05	0.000152	CcSEcCtD
Ropinirole—Anorexia—Paclitaxel—kidney cancer	6.68e-05	0.00015	CcSEcCtD
Ropinirole—Gastritis—Doxorubicin—kidney cancer	6.68e-05	0.00015	CcSEcCtD
Ropinirole—Alanine aminotransferase increased—Doxorubicin—kidney cancer	6.65e-05	0.00015	CcSEcCtD
Ropinirole—Muscular weakness—Doxorubicin—kidney cancer	6.65e-05	0.00015	CcSEcCtD
Ropinirole—Vision blurred—Capecitabine—kidney cancer	6.64e-05	0.00015	CcSEcCtD
Ropinirole—Vomiting—Sunitinib—kidney cancer	6.63e-05	0.000149	CcSEcCtD
Ropinirole—Body temperature increased—Gemcitabine—kidney cancer	6.62e-05	0.000149	CcSEcCtD
Ropinirole—Tremor—Capecitabine—kidney cancer	6.6e-05	0.000149	CcSEcCtD
Ropinirole—Rash—Sunitinib—kidney cancer	6.58e-05	0.000148	CcSEcCtD
Ropinirole—Dermatitis—Sunitinib—kidney cancer	6.57e-05	0.000148	CcSEcCtD
Ropinirole—Abdominal distension—Doxorubicin—kidney cancer	6.56e-05	0.000148	CcSEcCtD
Ropinirole—HTR2A—kidney—kidney cancer	6.56e-05	0.0239	CbGeAlD
Ropinirole—Hypotension—Paclitaxel—kidney cancer	6.55e-05	0.000147	CcSEcCtD
Ropinirole—Ill-defined disorder—Capecitabine—kidney cancer	6.54e-05	0.000147	CcSEcCtD
Ropinirole—Headache—Sunitinib—kidney cancer	6.54e-05	0.000147	CcSEcCtD
Ropinirole—Influenza—Doxorubicin—kidney cancer	6.52e-05	0.000147	CcSEcCtD
Ropinirole—Asthma—Doxorubicin—kidney cancer	6.52e-05	0.000147	CcSEcCtD
Ropinirole—Dysphagia—Doxorubicin—kidney cancer	6.52e-05	0.000147	CcSEcCtD
Ropinirole—Anaemia—Capecitabine—kidney cancer	6.52e-05	0.000147	CcSEcCtD
Ropinirole—Hypersensitivity—Vincristine—kidney cancer	6.5e-05	0.000146	CcSEcCtD
Ropinirole—Eosinophilia—Doxorubicin—kidney cancer	6.46e-05	0.000145	CcSEcCtD
Ropinirole—Nausea—Sorafenib—kidney cancer	6.44e-05	0.000145	CcSEcCtD
Ropinirole—Pancreatitis—Doxorubicin—kidney cancer	6.39e-05	0.000144	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.39e-05	0.000144	CcSEcCtD
Ropinirole—Malaise—Capecitabine—kidney cancer	6.36e-05	0.000143	CcSEcCtD
Ropinirole—Angina pectoris—Doxorubicin—kidney cancer	6.35e-05	0.000143	CcSEcCtD
Ropinirole—Insomnia—Paclitaxel—kidney cancer	6.34e-05	0.000143	CcSEcCtD
Ropinirole—Vertigo—Capecitabine—kidney cancer	6.33e-05	0.000143	CcSEcCtD
Ropinirole—Asthenia—Vincristine—kidney cancer	6.33e-05	0.000143	CcSEcCtD
Ropinirole—Syncope—Capecitabine—kidney cancer	6.32e-05	0.000142	CcSEcCtD
Ropinirole—Leukopenia—Capecitabine—kidney cancer	6.31e-05	0.000142	CcSEcCtD
Ropinirole—Paraesthesia—Paclitaxel—kidney cancer	6.29e-05	0.000142	CcSEcCtD
Ropinirole—CYP3A4—renal system—kidney cancer	6.28e-05	0.0229	CbGeAlD
Ropinirole—Vomiting—Dactinomycin—kidney cancer	6.28e-05	0.000141	CcSEcCtD
Ropinirole—Bronchitis—Doxorubicin—kidney cancer	6.27e-05	0.000141	CcSEcCtD
Ropinirole—Dyspnoea—Paclitaxel—kidney cancer	6.25e-05	0.000141	CcSEcCtD
Ropinirole—Somnolence—Paclitaxel—kidney cancer	6.23e-05	0.00014	CcSEcCtD
Ropinirole—Palpitations—Capecitabine—kidney cancer	6.23e-05	0.00014	CcSEcCtD
Ropinirole—Rash—Dactinomycin—kidney cancer	6.23e-05	0.00014	CcSEcCtD
Ropinirole—Nausea—Sunitinib—kidney cancer	6.2e-05	0.000139	CcSEcCtD
Ropinirole—Loss of consciousness—Capecitabine—kidney cancer	6.2e-05	0.000139	CcSEcCtD
Ropinirole—CYP2D6—renal system—kidney cancer	6.18e-05	0.0226	CbGeAlD
Ropinirole—Dyspepsia—Paclitaxel—kidney cancer	6.17e-05	0.000139	CcSEcCtD
Ropinirole—Cough—Capecitabine—kidney cancer	6.15e-05	0.000138	CcSEcCtD
Ropinirole—Dysuria—Doxorubicin—kidney cancer	6.1e-05	0.000137	CcSEcCtD
Ropinirole—Decreased appetite—Paclitaxel—kidney cancer	6.09e-05	0.000137	CcSEcCtD
Ropinirole—Hypertension—Capecitabine—kidney cancer	6.09e-05	0.000137	CcSEcCtD
Ropinirole—HTR2A—gonad—kidney cancer	6.08e-05	0.0222	CbGeAlD
Ropinirole—CYP3A4—kidney—kidney cancer	6.07e-05	0.0222	CbGeAlD
Ropinirole—Upper respiratory tract infection—Doxorubicin—kidney cancer	6.06e-05	0.000136	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.05e-05	0.000136	CcSEcCtD
Ropinirole—Fatigue—Paclitaxel—kidney cancer	6.04e-05	0.000136	CcSEcCtD
Ropinirole—Diarrhoea—Vincristine—kidney cancer	6.04e-05	0.000136	CcSEcCtD
Ropinirole—Pollakiuria—Doxorubicin—kidney cancer	6.02e-05	0.000136	CcSEcCtD
Ropinirole—Asthenia—Gemcitabine—kidney cancer	6.01e-05	0.000135	CcSEcCtD
Ropinirole—Chest pain—Capecitabine—kidney cancer	6e-05	0.000135	CcSEcCtD
Ropinirole—Arthralgia—Capecitabine—kidney cancer	6e-05	0.000135	CcSEcCtD
Ropinirole—Myalgia—Capecitabine—kidney cancer	6e-05	0.000135	CcSEcCtD
Ropinirole—Pain—Paclitaxel—kidney cancer	5.99e-05	0.000135	CcSEcCtD
Ropinirole—Constipation—Paclitaxel—kidney cancer	5.99e-05	0.000135	CcSEcCtD
Ropinirole—Anxiety—Capecitabine—kidney cancer	5.98e-05	0.000135	CcSEcCtD
Ropinirole—CYP2D6—kidney—kidney cancer	5.98e-05	0.0218	CbGeAlD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.96e-05	0.000134	CcSEcCtD
Ropinirole—Photosensitivity reaction—Doxorubicin—kidney cancer	5.95e-05	0.000134	CcSEcCtD
Ropinirole—Weight increased—Doxorubicin—kidney cancer	5.93e-05	0.000134	CcSEcCtD
Ropinirole—Discomfort—Capecitabine—kidney cancer	5.93e-05	0.000133	CcSEcCtD
Ropinirole—Pruritus—Gemcitabine—kidney cancer	5.92e-05	0.000133	CcSEcCtD
Ropinirole—Weight decreased—Doxorubicin—kidney cancer	5.9e-05	0.000133	CcSEcCtD
Ropinirole—Hyperglycaemia—Doxorubicin—kidney cancer	5.88e-05	0.000132	CcSEcCtD
Ropinirole—Dry mouth—Capecitabine—kidney cancer	5.87e-05	0.000132	CcSEcCtD
Ropinirole—Nausea—Dactinomycin—kidney cancer	5.87e-05	0.000132	CcSEcCtD
Ropinirole—Pneumonia—Doxorubicin—kidney cancer	5.85e-05	0.000132	CcSEcCtD
Ropinirole—Dizziness—Vincristine—kidney cancer	5.84e-05	0.000131	CcSEcCtD
Ropinirole—Infestation NOS—Doxorubicin—kidney cancer	5.81e-05	0.000131	CcSEcCtD
Ropinirole—Infestation—Doxorubicin—kidney cancer	5.81e-05	0.000131	CcSEcCtD
Ropinirole—Confusional state—Capecitabine—kidney cancer	5.8e-05	0.000131	CcSEcCtD
Ropinirole—Feeling abnormal—Paclitaxel—kidney cancer	5.78e-05	0.00013	CcSEcCtD
Ropinirole—Oedema—Capecitabine—kidney cancer	5.75e-05	0.000129	CcSEcCtD
Ropinirole—Gastrointestinal pain—Paclitaxel—kidney cancer	5.73e-05	0.000129	CcSEcCtD
Ropinirole—Diarrhoea—Gemcitabine—kidney cancer	5.73e-05	0.000129	CcSEcCtD
Ropinirole—Infection—Capecitabine—kidney cancer	5.72e-05	0.000129	CcSEcCtD
Ropinirole—Neuropathy peripheral—Doxorubicin—kidney cancer	5.7e-05	0.000128	CcSEcCtD
Ropinirole—Stomatitis—Doxorubicin—kidney cancer	5.67e-05	0.000128	CcSEcCtD
Ropinirole—Shock—Capecitabine—kidney cancer	5.66e-05	0.000127	CcSEcCtD
Ropinirole—Conjunctivitis—Doxorubicin—kidney cancer	5.65e-05	0.000127	CcSEcCtD
Ropinirole—Urinary tract infection—Doxorubicin—kidney cancer	5.65e-05	0.000127	CcSEcCtD
Ropinirole—Nervous system disorder—Capecitabine—kidney cancer	5.64e-05	0.000127	CcSEcCtD
Ropinirole—Thrombocytopenia—Capecitabine—kidney cancer	5.63e-05	0.000127	CcSEcCtD
Ropinirole—Tachycardia—Capecitabine—kidney cancer	5.61e-05	0.000126	CcSEcCtD
Ropinirole—Vomiting—Vincristine—kidney cancer	5.61e-05	0.000126	CcSEcCtD
Ropinirole—Skin disorder—Capecitabine—kidney cancer	5.59e-05	0.000126	CcSEcCtD
Ropinirole—Urticaria—Paclitaxel—kidney cancer	5.57e-05	0.000125	CcSEcCtD
Ropinirole—Rash—Vincristine—kidney cancer	5.57e-05	0.000125	CcSEcCtD
Ropinirole—Hyperhidrosis—Capecitabine—kidney cancer	5.56e-05	0.000125	CcSEcCtD
Ropinirole—Dermatitis—Vincristine—kidney cancer	5.56e-05	0.000125	CcSEcCtD
Ropinirole—Haematuria—Doxorubicin—kidney cancer	5.54e-05	0.000125	CcSEcCtD
Ropinirole—Abdominal pain—Paclitaxel—kidney cancer	5.54e-05	0.000125	CcSEcCtD
Ropinirole—Body temperature increased—Paclitaxel—kidney cancer	5.54e-05	0.000125	CcSEcCtD
Ropinirole—Headache—Vincristine—kidney cancer	5.53e-05	0.000124	CcSEcCtD
Ropinirole—Hepatobiliary disease—Doxorubicin—kidney cancer	5.5e-05	0.000124	CcSEcCtD
Ropinirole—Epistaxis—Doxorubicin—kidney cancer	5.48e-05	0.000123	CcSEcCtD
Ropinirole—Anorexia—Capecitabine—kidney cancer	5.48e-05	0.000123	CcSEcCtD
Ropinirole—Sinusitis—Doxorubicin—kidney cancer	5.45e-05	0.000123	CcSEcCtD
Ropinirole—Agranulocytosis—Doxorubicin—kidney cancer	5.43e-05	0.000122	CcSEcCtD
Ropinirole—Hypotension—Capecitabine—kidney cancer	5.38e-05	0.000121	CcSEcCtD
Ropinirole—Vomiting—Gemcitabine—kidney cancer	5.32e-05	0.00012	CcSEcCtD
Ropinirole—Bradycardia—Doxorubicin—kidney cancer	5.31e-05	0.00012	CcSEcCtD
Ropinirole—Rash—Gemcitabine—kidney cancer	5.28e-05	0.000119	CcSEcCtD
Ropinirole—Dermatitis—Gemcitabine—kidney cancer	5.27e-05	0.000119	CcSEcCtD
Ropinirole—Haemoglobin—Doxorubicin—kidney cancer	5.25e-05	0.000118	CcSEcCtD
Ropinirole—Headache—Gemcitabine—kidney cancer	5.25e-05	0.000118	CcSEcCtD
Ropinirole—Nausea—Vincristine—kidney cancer	5.24e-05	0.000118	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.24e-05	0.000118	CcSEcCtD
Ropinirole—Rhinitis—Doxorubicin—kidney cancer	5.23e-05	0.000118	CcSEcCtD
Ropinirole—Haemorrhage—Doxorubicin—kidney cancer	5.22e-05	0.000117	CcSEcCtD
Ropinirole—Insomnia—Capecitabine—kidney cancer	5.2e-05	0.000117	CcSEcCtD
Ropinirole—Hypoaesthesia—Doxorubicin—kidney cancer	5.19e-05	0.000117	CcSEcCtD
Ropinirole—Pharyngitis—Doxorubicin—kidney cancer	5.18e-05	0.000117	CcSEcCtD
Ropinirole—Paraesthesia—Capecitabine—kidney cancer	5.17e-05	0.000116	CcSEcCtD
Ropinirole—Hypersensitivity—Paclitaxel—kidney cancer	5.16e-05	0.000116	CcSEcCtD
Ropinirole—Urinary tract disorder—Doxorubicin—kidney cancer	5.15e-05	0.000116	CcSEcCtD
Ropinirole—Oedema peripheral—Doxorubicin—kidney cancer	5.14e-05	0.000116	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—kidney cancer	5.13e-05	0.000115	CcSEcCtD
Ropinirole—Dyspnoea—Capecitabine—kidney cancer	5.13e-05	0.000115	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—kidney cancer	5.12e-05	0.000115	CcSEcCtD
Ropinirole—Dyspepsia—Capecitabine—kidney cancer	5.06e-05	0.000114	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—kidney cancer	5.03e-05	0.000113	CcSEcCtD
Ropinirole—Asthenia—Paclitaxel—kidney cancer	5.03e-05	0.000113	CcSEcCtD
Ropinirole—Decreased appetite—Capecitabine—kidney cancer	5e-05	0.000113	CcSEcCtD
Ropinirole—Nausea—Gemcitabine—kidney cancer	4.97e-05	0.000112	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Capecitabine—kidney cancer	4.97e-05	0.000112	CcSEcCtD
Ropinirole—Fatigue—Capecitabine—kidney cancer	4.96e-05	0.000112	CcSEcCtD
Ropinirole—Pruritus—Paclitaxel—kidney cancer	4.96e-05	0.000112	CcSEcCtD
Ropinirole—Pain—Capecitabine—kidney cancer	4.92e-05	0.000111	CcSEcCtD
Ropinirole—Constipation—Capecitabine—kidney cancer	4.92e-05	0.000111	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—kidney cancer	4.88e-05	0.00011	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—kidney cancer	4.87e-05	0.00011	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—kidney cancer	4.84e-05	0.000109	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—kidney cancer	4.84e-05	0.000109	CcSEcCtD
Ropinirole—Diarrhoea—Paclitaxel—kidney cancer	4.8e-05	0.000108	CcSEcCtD
Ropinirole—Feeling abnormal—Capecitabine—kidney cancer	4.74e-05	0.000107	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—kidney cancer	4.74e-05	0.000107	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—kidney cancer	4.71e-05	0.000106	CcSEcCtD
Ropinirole—Gastrointestinal pain—Capecitabine—kidney cancer	4.7e-05	0.000106	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—kidney cancer	4.7e-05	0.000106	CcSEcCtD
Ropinirole—Chills—Doxorubicin—kidney cancer	4.68e-05	0.000105	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—kidney cancer	4.66e-05	0.000105	CcSEcCtD
Ropinirole—Dizziness—Paclitaxel—kidney cancer	4.64e-05	0.000104	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—kidney cancer	4.61e-05	0.000104	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—kidney cancer	4.57e-05	0.000103	CcSEcCtD
Ropinirole—Urticaria—Capecitabine—kidney cancer	4.57e-05	0.000103	CcSEcCtD
Ropinirole—Abdominal pain—Capecitabine—kidney cancer	4.55e-05	0.000102	CcSEcCtD
Ropinirole—Body temperature increased—Capecitabine—kidney cancer	4.55e-05	0.000102	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—kidney cancer	4.54e-05	0.000102	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—kidney cancer	4.48e-05	0.000101	CcSEcCtD
Ropinirole—Tension—Doxorubicin—kidney cancer	4.46e-05	0.0001	CcSEcCtD
Ropinirole—Vomiting—Paclitaxel—kidney cancer	4.46e-05	0.0001	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—kidney cancer	4.45e-05	0.0001	CcSEcCtD
Ropinirole—Rash—Paclitaxel—kidney cancer	4.42e-05	9.95e-05	CcSEcCtD
Ropinirole—Dermatitis—Paclitaxel—kidney cancer	4.42e-05	9.94e-05	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—kidney cancer	4.41e-05	9.93e-05	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—kidney cancer	4.4e-05	9.89e-05	CcSEcCtD
Ropinirole—Headache—Paclitaxel—kidney cancer	4.39e-05	9.88e-05	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—kidney cancer	4.37e-05	9.83e-05	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—kidney cancer	4.28e-05	9.64e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Capecitabine—kidney cancer	4.24e-05	9.54e-05	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—kidney cancer	4.22e-05	9.49e-05	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—kidney cancer	4.2e-05	9.45e-05	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—kidney cancer	4.18e-05	9.4e-05	CcSEcCtD
Ropinirole—Nausea—Paclitaxel—kidney cancer	4.16e-05	9.37e-05	CcSEcCtD
Ropinirole—Asthenia—Capecitabine—kidney cancer	4.13e-05	9.29e-05	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—kidney cancer	4.1e-05	9.22e-05	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—kidney cancer	4.08e-05	9.19e-05	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—kidney cancer	4.07e-05	9.17e-05	CcSEcCtD
Ropinirole—Pruritus—Capecitabine—kidney cancer	4.07e-05	9.16e-05	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—kidney cancer	4.07e-05	9.15e-05	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—kidney cancer	4.02e-05	9.04e-05	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—kidney cancer	3.99e-05	8.99e-05	CcSEcCtD
Ropinirole—Cough—Doxorubicin—kidney cancer	3.96e-05	8.92e-05	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—kidney cancer	3.94e-05	8.86e-05	CcSEcCtD
Ropinirole—Diarrhoea—Capecitabine—kidney cancer	3.94e-05	8.86e-05	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—kidney cancer	3.92e-05	8.83e-05	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—kidney cancer	3.87e-05	8.71e-05	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—kidney cancer	3.87e-05	8.71e-05	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—kidney cancer	3.87e-05	8.71e-05	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—kidney cancer	3.85e-05	8.68e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.84e-05	8.65e-05	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—kidney cancer	3.82e-05	8.6e-05	CcSEcCtD
Ropinirole—Dizziness—Capecitabine—kidney cancer	3.8e-05	8.56e-05	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—kidney cancer	3.78e-05	8.51e-05	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—kidney cancer	3.74e-05	8.42e-05	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—kidney cancer	3.71e-05	8.35e-05	CcSEcCtD
Ropinirole—Infection—Doxorubicin—kidney cancer	3.68e-05	8.29e-05	CcSEcCtD
Ropinirole—Vomiting—Capecitabine—kidney cancer	3.66e-05	8.23e-05	CcSEcCtD
Ropinirole—Shock—Doxorubicin—kidney cancer	3.65e-05	8.21e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—kidney cancer	3.64e-05	8.18e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—kidney cancer	3.63e-05	8.17e-05	CcSEcCtD
Ropinirole—Rash—Capecitabine—kidney cancer	3.63e-05	8.16e-05	CcSEcCtD
Ropinirole—Dermatitis—Capecitabine—kidney cancer	3.62e-05	8.16e-05	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—kidney cancer	3.62e-05	8.15e-05	CcSEcCtD
Ropinirole—Headache—Capecitabine—kidney cancer	3.6e-05	8.11e-05	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—kidney cancer	3.6e-05	8.11e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—kidney cancer	3.58e-05	8.07e-05	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—kidney cancer	3.53e-05	7.96e-05	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—kidney cancer	3.47e-05	7.8e-05	CcSEcCtD
Ropinirole—Nausea—Capecitabine—kidney cancer	3.42e-05	7.69e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.38e-05	7.6e-05	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—kidney cancer	3.35e-05	7.55e-05	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—kidney cancer	3.33e-05	7.49e-05	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—kidney cancer	3.31e-05	7.44e-05	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—kidney cancer	3.3e-05	7.42e-05	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—kidney cancer	3.26e-05	7.35e-05	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—kidney cancer	3.22e-05	7.25e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.2e-05	7.21e-05	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—kidney cancer	3.2e-05	7.2e-05	CcSEcCtD
Ropinirole—Pain—Doxorubicin—kidney cancer	3.17e-05	7.14e-05	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—kidney cancer	3.17e-05	7.14e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—kidney cancer	3.06e-05	6.88e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—kidney cancer	3.03e-05	6.82e-05	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—kidney cancer	2.95e-05	6.63e-05	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—kidney cancer	2.93e-05	6.6e-05	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—kidney cancer	2.93e-05	6.6e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—kidney cancer	2.73e-05	6.15e-05	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—kidney cancer	2.66e-05	5.99e-05	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—kidney cancer	2.62e-05	5.9e-05	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—kidney cancer	2.54e-05	5.71e-05	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—kidney cancer	2.45e-05	5.52e-05	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—kidney cancer	2.36e-05	5.31e-05	CcSEcCtD
Ropinirole—Rash—Doxorubicin—kidney cancer	2.34e-05	5.26e-05	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—kidney cancer	2.34e-05	5.26e-05	CcSEcCtD
Ropinirole—Headache—Doxorubicin—kidney cancer	2.32e-05	5.23e-05	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—kidney cancer	2.2e-05	4.96e-05	CcSEcCtD
Ropinirole—HTR1A—Signaling by GPCR—KRAS—kidney cancer	5e-06	0.000131	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—KRAS—kidney cancer	4.98e-06	0.00013	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PTEN—kidney cancer	4.97e-06	0.00013	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KDR—kidney cancer	4.96e-06	0.00013	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ABCB1—kidney cancer	4.94e-06	0.000129	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTT1—kidney cancer	4.92e-06	0.000129	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ACHE—kidney cancer	4.92e-06	0.000129	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CCND1—kidney cancer	4.92e-06	0.000129	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—JUN—kidney cancer	4.9e-06	0.000128	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—PIK3CA—kidney cancer	4.9e-06	0.000128	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—MAPK3—kidney cancer	4.89e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CTNNB1—kidney cancer	4.87e-06	0.000127	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CDKN1B—kidney cancer	4.86e-06	0.000127	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—POMC—kidney cancer	4.86e-06	0.000127	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—KRAS—kidney cancer	4.84e-06	0.000127	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—MAPK3—kidney cancer	4.81e-06	0.000126	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—BRAF—kidney cancer	4.8e-06	0.000125	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CDKN1B—kidney cancer	4.79e-06	0.000125	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GSTM1—kidney cancer	4.79e-06	0.000125	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—POMC—kidney cancer	4.78e-06	0.000125	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—PIK3CA—kidney cancer	4.76e-06	0.000125	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL2—kidney cancer	4.75e-06	0.000124	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—PIK3CA—kidney cancer	4.75e-06	0.000124	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PTEN—kidney cancer	4.74e-06	0.000124	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—RAF1—kidney cancer	4.72e-06	0.000124	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—BRAF—kidney cancer	4.72e-06	0.000123	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—RELA—kidney cancer	4.7e-06	0.000123	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL2—kidney cancer	4.69e-06	0.000123	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—ERBB2—kidney cancer	4.67e-06	0.000122	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—VEGFA—kidney cancer	4.66e-06	0.000122	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SCARB1—kidney cancer	4.66e-06	0.000122	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—MAPK1—kidney cancer	4.65e-06	0.000122	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CCND1—kidney cancer	4.64e-06	0.000121	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—JUN—kidney cancer	4.63e-06	0.000121	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MTOR—kidney cancer	4.61e-06	0.000121	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS1—kidney cancer	4.61e-06	0.000121	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TP53—kidney cancer	4.6e-06	0.00012	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—PIK3CA—kidney cancer	4.59e-06	0.00012	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CTNNB1—kidney cancer	4.59e-06	0.00012	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—MAPK1—kidney cancer	4.57e-06	0.00012	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CCND1—kidney cancer	4.57e-06	0.00012	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—PIK3CA—kidney cancer	4.57e-06	0.00012	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—APC—kidney cancer	4.57e-06	0.000119	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KIT—kidney cancer	4.57e-06	0.000119	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—JUN—kidney cancer	4.56e-06	0.000119	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—VEGFA—kidney cancer	4.56e-06	0.000119	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RAF1—kidney cancer	4.56e-06	0.000119	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.54e-06	0.000119	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RELA—kidney cancer	4.54e-06	0.000119	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RAF1—kidney cancer	4.54e-06	0.000119	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CTNNB1—kidney cancer	4.53e-06	0.000118	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PSMD7—kidney cancer	4.52e-06	0.000118	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RELA—kidney cancer	4.52e-06	0.000118	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—ERBB2—kidney cancer	4.51e-06	0.000118	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—VEGFA—kidney cancer	4.49e-06	0.000117	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—ERBB2—kidney cancer	4.49e-06	0.000117	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.48e-06	0.000117	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PTEN—kidney cancer	4.47e-06	0.000117	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MTOR—kidney cancer	4.45e-06	0.000116	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PTEN—kidney cancer	4.45e-06	0.000116	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—PIK3CA—kidney cancer	4.45e-06	0.000116	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	4.44e-06	0.000116	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MTOR—kidney cancer	4.43e-06	0.000116	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTP1—kidney cancer	4.42e-06	0.000116	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PTEN—kidney cancer	4.41e-06	0.000115	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RAF1—kidney cancer	4.41e-06	0.000115	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MAPK3—kidney cancer	4.41e-06	0.000115	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RELA—kidney cancer	4.39e-06	0.000115	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—KRAS—kidney cancer	4.39e-06	0.000115	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	4.37e-06	0.000114	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.37e-06	0.000114	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—ERBB2—kidney cancer	4.37e-06	0.000114	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—POMC—kidney cancer	4.35e-06	0.000114	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	4.33e-06	0.000113	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—KRAS—kidney cancer	4.32e-06	0.000113	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MAPK3—kidney cancer	4.32e-06	0.000113	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MTOR—kidney cancer	4.31e-06	0.000113	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—BRAF—kidney cancer	4.29e-06	0.000112	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MYC—kidney cancer	4.29e-06	0.000112	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—BCHE—kidney cancer	4.29e-06	0.000112	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—VEGFA—kidney cancer	4.29e-06	0.000112	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MAPK3—kidney cancer	4.25e-06	0.000111	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL2—kidney cancer	4.24e-06	0.000111	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.23e-06	0.000111	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MYC—kidney cancer	4.2e-06	0.00011	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MAPK1—kidney cancer	4.19e-06	0.00011	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ABCB1—kidney cancer	4.18e-06	0.000109	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	4.18e-06	0.000109	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	4.16e-06	0.000109	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	4.16e-06	0.000109	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—kidney cancer	4.15e-06	0.000108	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MYC—kidney cancer	4.13e-06	0.000108	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCND1—kidney cancer	4.13e-06	0.000108	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—JUN—kidney cancer	4.12e-06	0.000108	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MAPK1—kidney cancer	4.11e-06	0.000107	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	4.09e-06	0.000107	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL2—kidney cancer	4.09e-06	0.000107	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.09e-06	0.000107	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL2—kidney cancer	4.07e-06	0.000106	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTM1—kidney cancer	4.06e-06	0.000106	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK3—kidney cancer	4.05e-06	0.000106	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CDKN1B—kidney cancer	4.04e-06	0.000106	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—kidney cancer	4.04e-06	0.000106	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MAPK1—kidney cancer	4.04e-06	0.000106	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	4.03e-06	0.000106	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RAF1—kidney cancer	4e-06	0.000105	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—kidney cancer	3.99e-06	0.000104	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RELA—kidney cancer	3.99e-06	0.000104	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCND1—kidney cancer	3.99e-06	0.000104	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PTEN—kidney cancer	3.99e-06	0.000104	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—JUN—kidney cancer	3.98e-06	0.000104	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	3.98e-06	0.000104	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	3.97e-06	0.000104	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCND1—kidney cancer	3.97e-06	0.000104	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ERBB2—kidney cancer	3.96e-06	0.000104	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—KRAS—kidney cancer	3.96e-06	0.000104	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—JUN—kidney cancer	3.96e-06	0.000104	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL2—kidney cancer	3.96e-06	0.000104	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	3.95e-06	0.000103	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—kidney cancer	3.94e-06	0.000103	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RAF1—kidney cancer	3.94e-06	0.000103	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	3.93e-06	0.000103	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	3.93e-06	0.000103	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RELA—kidney cancer	3.92e-06	0.000103	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MTOR—kidney cancer	3.91e-06	0.000102	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ERBB2—kidney cancer	3.9e-06	0.000102	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—KRAS—kidney cancer	3.88e-06	0.000101	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCND1—kidney cancer	3.86e-06	0.000101	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK1—kidney cancer	3.86e-06	0.000101	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.85e-06	0.000101	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—JUN—kidney cancer	3.85e-06	0.000101	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTEN—kidney cancer	3.85e-06	0.000101	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MTOR—kidney cancer	3.85e-06	0.000101	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTEN—kidney cancer	3.83e-06	0.0001	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK3—kidney cancer	3.82e-06	0.0001	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	3.82e-06	9.99e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—kidney cancer	3.82e-06	9.98e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK3—kidney cancer	3.77e-06	9.87e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTEN—kidney cancer	3.72e-06	9.74e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—kidney cancer	3.72e-06	9.73e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—kidney cancer	3.67e-06	9.6e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1B—kidney cancer	3.67e-06	9.6e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—kidney cancer	3.64e-06	9.53e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	3.64e-06	9.52e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK1—kidney cancer	3.64e-06	9.52e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTEN—kidney cancer	3.62e-06	9.46e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	3.61e-06	9.45e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	3.61e-06	9.44e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	3.6e-06	9.42e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—kidney cancer	3.59e-06	9.39e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK1—kidney cancer	3.59e-06	9.39e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RAF1—kidney cancer	3.58e-06	9.38e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RELA—kidney cancer	3.57e-06	9.33e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	3.56e-06	9.32e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	3.55e-06	9.28e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—kidney cancer	3.53e-06	9.24e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—kidney cancer	3.52e-06	9.21e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—kidney cancer	3.51e-06	9.17e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—kidney cancer	3.5e-06	9.16e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MTOR—kidney cancer	3.5e-06	9.15e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—JUN—kidney cancer	3.49e-06	9.14e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—kidney cancer	3.47e-06	9.09e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CTNNB1—kidney cancer	3.47e-06	9.07e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—kidney cancer	3.46e-06	9.04e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—kidney cancer	3.45e-06	9.02e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—kidney cancer	3.44e-06	9.01e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—JUN—kidney cancer	3.44e-06	8.99e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—kidney cancer	3.44e-06	8.99e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	3.41e-06	8.92e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTP1—kidney cancer	3.41e-06	8.92e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	3.41e-06	8.91e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—kidney cancer	3.39e-06	8.87e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—kidney cancer	3.39e-06	8.87e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—POMC—kidney cancer	3.39e-06	8.86e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTEN—kidney cancer	3.38e-06	8.84e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	3.36e-06	8.8e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	3.35e-06	8.76e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTEN—kidney cancer	3.32e-06	8.69e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—kidney cancer	3.31e-06	8.66e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK3—kidney cancer	3.29e-06	8.6e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	3.28e-06	8.59e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK3—kidney cancer	3.27e-06	8.56e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	3.24e-06	8.48e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—kidney cancer	3.24e-06	8.47e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ABCB1—kidney cancer	3.23e-06	8.44e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—kidney cancer	3.21e-06	8.41e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—kidney cancer	3.2e-06	8.36e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	3.18e-06	8.32e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—kidney cancer	3.18e-06	8.32e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.16e-06	8.27e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—kidney cancer	3.16e-06	8.26e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—kidney cancer	3.14e-06	8.22e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—kidney cancer	3.13e-06	8.2e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—kidney cancer	3.13e-06	8.2e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK1—kidney cancer	3.13e-06	8.18e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—JUN—kidney cancer	3.13e-06	8.18e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—kidney cancer	3.11e-06	8.15e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK1—kidney cancer	3.11e-06	8.14e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	3.1e-06	8.12e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—kidney cancer	3.09e-06	8.09e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—kidney cancer	3.06e-06	8.01e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—kidney cancer	3.05e-06	7.99e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—kidney cancer	3.05e-06	7.98e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	3.03e-06	7.92e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTEN—kidney cancer	3.02e-06	7.91e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—kidney cancer	3.01e-06	7.88e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—kidney cancer	3e-06	7.85e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.97e-06	7.77e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—kidney cancer	2.95e-06	7.73e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—kidney cancer	2.94e-06	7.69e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK3—kidney cancer	2.89e-06	7.55e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—POMC—kidney cancer	2.87e-06	7.51e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—kidney cancer	2.86e-06	7.48e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK3—kidney cancer	2.84e-06	7.43e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	2.81e-06	7.36e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—kidney cancer	2.81e-06	7.34e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—kidney cancer	2.76e-06	7.23e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.75e-06	7.18e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	2.73e-06	7.14e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—kidney cancer	2.72e-06	7.12e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	2.71e-06	7.1e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK1—kidney cancer	2.7e-06	7.07e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—kidney cancer	2.7e-06	7.07e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	2.7e-06	7.06e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	2.63e-06	6.87e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—kidney cancer	2.63e-06	6.87e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—kidney cancer	2.61e-06	6.83e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—kidney cancer	2.59e-06	6.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	2.58e-06	6.76e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—kidney cancer	2.55e-06	6.68e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.55e-06	6.67e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—kidney cancer	2.54e-06	6.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.51e-06	6.57e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.46e-06	6.43e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.38e-06	6.23e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTEN—kidney cancer	2.36e-06	6.16e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	2.34e-06	6.13e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.32e-06	6.07e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—kidney cancer	2.31e-06	6.03e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—kidney cancer	2.29e-06	5.99e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—kidney cancer	2.27e-06	5.93e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—POMC—kidney cancer	2.21e-06	5.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.13e-06	5.58e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.06e-06	5.4e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTEN—kidney cancer	2e-06	5.22e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—kidney cancer	1.77e-06	4.62e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.66e-06	4.35e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTEN—kidney cancer	1.54e-06	4.03e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.41e-06	3.68e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.09e-06	2.84e-05	CbGpPWpGaD
